These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33139601)

  • 61. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of gut microbiota on neurological diseases: Diet composition and novel treatments.
    Larroya-García A; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2019; 59(19):3102-3116. PubMed ID: 29870270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
    Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
    Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders.
    Boicean A; Ichim C; Todor SB; Anderco P; Popa ML
    Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732276
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy.
    Kang Y; Cai Y
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):229-235. PubMed ID: 29877092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?
    Ilan Y
    Clin Exp Gastroenterol; 2019; 12():209-217. PubMed ID: 31190948
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
    Verbeke KA; Boesmans L; Boets E
    Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics.
    Satokari R
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443276
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus.
    Salgaço MK; Oliveira LGS; Costa GN; Bianchi F; Sivieri K
    Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9229-9238. PubMed ID: 31664483
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The potential role of gut microbiota in pancreatic disease: A systematic review.
    Memba R; Duggan SN; Ni Chonchubhair HM; Griffin OM; Bashir Y; O'Connor DB; Murphy A; McMahon J; Volcov Y; Ryan BM; Conlon KC
    Pancreatology; 2017; 17(6):867-874. PubMed ID: 28935288
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gut microbiota in autism and mood disorders.
    Mangiola F; Ianiro G; Franceschi F; Fagiuoli S; Gasbarrini G; Gasbarrini A
    World J Gastroenterol; 2016 Jan; 22(1):361-8. PubMed ID: 26755882
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fecal Microbiota Transplantation for the Critically Ill Patient.
    Limketkai BN; Hendler S; Ting PS; Parian AM
    Nutr Clin Pract; 2019 Feb; 34(1):73-79. PubMed ID: 30561131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Altered Gut Microbic Flora and Haemorrhoids: Could They Have a Possible Relationship?
    Palumbo VD; Tutino R; Messina M; Santarelli M; Nigro C; Lo Secco G; Piceni C; Montanari E; Barletta G; Venturelli P; Geraci G; Bonventre S; Lo Monte AI
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983199
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy.
    Binda C; Gibiino G; Sbrancia M; Coluccio C; Cazzato M; Carloni L; Cucchetti A; Ercolani G; Sambri V; Fabbri C
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36611999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.